Results 41 to 50 of about 273,066 (341)

Comparative analysis and identification of spike mutations in Iranian COVID-19 samples from the first three waves of disease

open access: yesAdvanced Biomedical Research, 2023
Background: The spike surface glycoprotein of SARS-CoV-2 is the essential protein in virus attachment to the target cell and cell entrance. As this protein contains immunodominant epitopes and is the main target for immune recognition, it is the critical
Parisa Shoaei   +6 more
doaj   +1 more source

The Appropriate Use of Testing for COVID-19 [PDF]

open access: yes, 2020
Many public officials are calling for increased testing for the 2019 novel coronavirus disease (COVID-19), and some governments have taken extraordinary measures to increase the availability of testing.
Zitek, Tony
core  

Capturing the ‘ome’ : the expanding molecular toolbox for RNA and DNA library construction [PDF]

open access: yes, 2018
All sequencing experiments and most functional genomics screens rely on the generation of libraries to comprehensively capture pools of targeted sequences.
Boone, Morgane   +2 more
core   +2 more sources

Focus on chirality of HIV-​1 non-​nucleoside reverse transcriptase inhibitors [PDF]

open access: yes, 2016
Chiral HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are of great interest since one enantiomer is often more potent than the corresponding counterpart against the HIV-1 wild type (WT) and the HIV-1 drug resistant mutant strains.
Famiglini, Valeria, Silvestri, Romano
core   +2 more sources

Molecularly imprinted nanoparticles for inhibiting ribonuclease in reverse transcriptase polymerase chain reaction [PDF]

open access: yesThe Analyst, 2018
We showed that molecularly imprinted nanoparticles (nanoMIPs) could efficiently inhibit the activities of the RNase in RT-PCR reactions, demonstrating that the tailor-made nanomaterials are very promising for use in routine biological assays.
Xiaotong Feng   +4 more
openaire   +5 more sources

Quantitative Reverse Transcriptase Polymerase Chain Reaction

open access: yes, 2007
Since the first documentation of real-time polymerase chain reaction (PCR),(1) it has been used for an increasing and diverse number of applications, including mRNA expression studies, DNA copy number measurements in genomic or viral DNAs,(2–7) allelic discrimination assays,(8,9) expression analysis of specific splice variants of genes(10–13) and gene ...
Gommersall, Lyndon M.   +3 more
openaire   +1 more source

Fetal Cytokine Expression In UteroDetected by Reverse Transcriptase Polymerase Chain Reaction [PDF]

open access: yesPediatric Research, 1995
Cytokine expression at the maternal-fetal interface is well documented. Some authors have postulated the existence of a bidirectional cytokine signaling mechanism that is critical to the maintenance of normal pregnancy. The role of the fetus (versus fetally derived placental tissues) in this process is unknown.
J N, Jarvis   +4 more
openaire   +2 more sources

A reverse transcriptase polymerase chain reaction assay for the detection of thermophilicCampylobacterspp.

open access: yesMolecular and Cellular Probes, 1998
A novel method was developed for the detection of thermophilic enteropathogenic campylobacters based on the detection of mRNA using the reverse transcriptase polymerase chain reaction (RT-PCR). The RNA extraction method, DNase treatment and RT-PCR assay were shown to be specific for mRNA.
A D, Sails   +4 more
openaire   +2 more sources

Hilar lymphadenopathy, a novel finding in the setting of coronavirus disease (COVID-19): a case report

open access: yesJournal of Medical Case Reports, 2020
Background As the outbreak of coronavirus disease 2019 (COVID-19) has progressed, computed tomography has emerged as an integral part of the diagnosis alongside reverse transcriptase–polymerase chain reaction assays.
Mohsin Sheraz Mughal   +5 more
doaj   +1 more source

Detection of H275Y Mutation of A(H1N1)pdmO9 Viruses Using a Real-time RT-PCR Assay in Mongolia

open access: yesCentral Asian Journal of Medical Sciences, 2016
Objectives: Oseltamivir is recommended as a first-line drug for the prophylaxis and treatment of influenza A(H1N1)pdmO9 infection worldwide. However, oseltamivir-resistant influenza A(H1N1)pdmO9 viruses have been identified and are mostly associated with
Naranzul Tsedenbal   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy